Comorbidity in Australia: findings of the 2007 National Survey of Mental Health and Wellbeing

References

• Kessler RC, Wang PS. The descriptive epidemiology of commonly occurring mental disorders in the United States. Annu Rev Public Health 2008; 29: 115–129
   PubMed Web of Science ®Google Scholar
• Burns L, Teesson M. Alcohol use disorders comorbid with anxiety, depression and drug use disorders. Findings from the Australian National Survey of Mental Health and Wellbeing. Drug Alcohol Depend 2002; 68: 299–307
   PubMed Web of Science ®Google Scholar
• Kessler RC, McGonagle KA, Zhao S, et al. Lifetime and 12-month prevalence of DSM-III-R psychiatric disorders in the United States. Results from the National Comorbidity Survey. Arch Gen Psychiatry 1994; 51: 8–19
   PubMed Web of Science ®Google Scholar
• Kessler RC, Chiu WT, Demler O, Merikangas KR, Walters EE. Prevalence, severity, and comorbidity of 12-month DSM-IV disorders in the National Comorbidity Survey Replication. Arch Gen Psychiatry 2005; 62: 617–627
   PubMed Web of Science ®Google Scholar
• Compton WM, Thomas YF, Stinson FS, Grant BF. Prevalence, correlates, disability, and comorbidity of DSM-IV drug abuse and dependence in the United States: results from the National Epidemiologic Survey on Alcohol and Related Conditions. Arch Gen Psychiatry 2007; 64: 566–576
   PubMed Web of Science ®Google Scholar
• Hasin DS, Stinson FS, Ogburn E, Grant BF. Prevalence, correlates, disability, and comorbidity of DSM-IV alcohol abuse and dependence in the United States: results from the National Epidemiologic Survey on Alcohol and Related Conditions. Arch Gen Psychiatry 2007; 64: 830–842
   PubMed Web of Science ®Google Scholar
• Gratzer D, Levitan RD, Sheldon T, Toneatto T, Rector NA, Goering P. Lifetime rates of alcoholism in adults with anxiety, depression, or co-morbid depression/anxiety: a community survey of Ontario. J Affect Disord 2004; 79: 209–215
   PubMed Web of Science ®Google Scholar
• de Graaf R, Bijl RV, Smit F, Vollebergh WA, Spijker J. Risk factors for 12-month comorbidity of mood, anxiety, and substance use disorders: findings from the Netherlands Mental Health Survey and Incidence Study. Am J Psychiatry 2002; 159: 620–629
   PubMed Web of Science ®Google Scholar
• John U, Meyer C, Rumpf HJ, Hapke U. Smoking, nicotine dependence and psychiatric comorbidity: a population-based study including smoking cessation after three years. Drug Alcohol Depend 2004; 76: 287–295
   PubMed Web of Science ®Google Scholar
• Farrell M, Howes S, Bebbington P, et al. Nicotine, alcohol and drug dependence and psychiatric comorbidity. Results of a national household survey. Br J Psychiatry 2001; 179: 432–437
   PubMed Web of Science ®Google Scholar
• Scott KM, Browne MAO, McGee MA, Wells JE. Mental-physical comorbidity in Te Rau Hinengaro: the New Zealand Mental Health Survey. Aust N Z J Psychiatry 2006; 40: 882–888
   PubMed Web of Science ®Google Scholar
• Scott KM, McGee MA, Browne MAO, Wells JE. Mental disorder comorbidity in Te Rau Hinengaro: the New Zealand Mental Health Survey. Aust N Z J Psychiatry 2006; 40: 875–881
   PubMed Web of Science ®Google Scholar
• Andrews G, Henderson S, Hall W. Prevalence, comorbidity, disability and service utilisation: overview of the Australian National Mental Health Survey. Br J Psychiatry 2001; 178: 145–153
   PubMed Web of Science ®Google Scholar
• Teesson M, Hall WD, Lynskey M, Degenhardt L. Alcohol- and drug-use disorders in Australia: implications of the National Survey of Mental Health and Wellbeing. Aust N Z J Psychiatry 2000; 34: 206–213
   PubMed Web of Science ®Google Scholar
• Hall W, Degenhardt L, Teesson M. Understanding and responding to comorbidity: the need to broaden the research base?. Addict Behav 2008; 34: 526–530
   Web of Science ®Google Scholar
• Merikangas KR, Kalaydjian A. Magnitude and impact of comorbidity of mental disorders from epidemiologic surveys. Curr Opin Psychiatry 2007; 20: 353–358
   PubMed Web of Science ®Google Scholar
• Jorm AF. National surveys of mental disorders: are they researching scientific facts or constructing useful myths? Editorial. Aust N Z J Psychiatry 2006; 40: 830–834
   PubMed Web of Science ®Google Scholar
• Mills KL, Teesson M, Ross J, Peters L. Trauma, PTSD, and substance use disorders: findings from the Australian National Survey of Mental Health and Wellbeing. Am J Psychiatry 2006; 163: 652–658
   PubMed Web of Science ®Google Scholar
• Teesson M, Degenhardt L, Proudfoot H, Hall W, Lynskey M. How common is comorbidity and why does it occur?. Aust Psychol 2005; 40: 81–87
   Web of Science ®Google Scholar
• Teesson M, Mills K, Ross J, Darke S, Williamson A, Havard A. The impact of treatment on 3 years’ outcome for heroin dependence: findings from the Australian Treatment Outcome Study (ATOS). Addiction 2008; 103: 80–88
   PubMed Web of Science ®Google Scholar
• Kessler RC, Wai TC, Demler O, Walters EE. Prevalence, severity, and comorbidity of 12-month DSM-IV disorders in the National Comorbidity Survey Replication. Arch Gen Psychiatry 2005; 62: 617–627
   PubMed Web of Science ®Google Scholar
• Kessler RC, Berglund P, Demler O, Jin R, Merikangas KR, Walters EE. Lifetime prevalence and age-of-onset distributions of DSM-IV disorders in the National Comorbidity Survey Replication. Arch Gen Psychiatry 2005; 62: 593–602
   PubMed Web of Science ®Google Scholar
• Degenhardt L, Bohnert KM, Anthony JC. Case ascertainment of alcohol dependence in general population surveys: ‘gated’ versus ‘ungated’ approaches. Int J Methods Psychiatr Res 2007; 16: 111–123
   PubMed Web of Science ®Google Scholar
• Grant BF, Compton WM, Crowley TJ, et al. Errors in assessing DSM-IV substance use disorders letter. Arch Gen Psychiatry 2007; 64: 379–380
   PubMed Web of Science ®Google Scholar
• Degenhardt L, Cheng H, Anthony JC. Assessing cannabis dependence in community surveys: methodological issues. Int J Methods Psychiatr Res 2007; 16: 43–51
   PubMed Web of Science ®Google Scholar
• Scott KM, Von Korff M, Alonso J, Angermeyer MC, Bromet E. Mental-physical co-morbidity and its relationship with disability: results from the worlds mental health surveys. Psychol Med 2009; 39: 33–43
   PubMed Web of Science ®Google Scholar
• Slade T, Johnston A, Oakley-Browne MA, Andrews G, Whiteford H. 2007 National Survey of Mental Health and Wellbeing: methods and key findings. Aust N Z J Psychiatry 2009; 43:XX–XX.
   Web of Science ®Google Scholar
• Teesson M, Degebhardt L, Hall W. Addictions. Psychology Press, New York 2002
   Google Scholar
• Hackett ML, Anderson CS, House A, Xia J. Interventions for treating depression after stroke. Cochrane Database Syst Rev 2008; (4):CD003437.
   PubMed Web of Science ®Google Scholar
• Cerda M, Sagdeo A, Galea S. Comorbid forms of psychopathology: key patterns and future research directions. Epidemiol Rev 2008; 30: 155–177
   PubMed Web of Science ®Google Scholar
• Grant BF, Goldstein RB, Chou SP , et al. Sociodemographic and psychopathologic predictors of first incidence of DSM-IV substance use, mood and anxiety disorders: results from the Wave 2 National Epidemiologic Survey on Alcohol and Related Conditions. Mol Psychiatry; 2008 Apr 22 [Epub ahead of print].
   Google Scholar
• Teesson M, Proudfoot H, Comorbid mental disorders and substance use disorders: epidemiology, prevention and treatment. Canberra: Commonwealth Department of Health and Ageing, 2003.
   Google Scholar
• Davis L, Uezato A, Newell JM, Frazier E. Major depression and comorbid substance use disorders. Curr Opin Psychiatry 2008; 21: 14–18
   PubMed Web of Science ®Google Scholar
• Nunes EV, Levin FR. Treatment of depression in patients with alcohol or other drug dependence: a meta-analysis. JAMA 2004; 291: 1887–1896
   PubMed Web of Science ®Google Scholar
• Baillie A, Sannibale C. Anxiety and drug and alcohol problems. Clinical handbook of co-existing mental health and drug and alcohol problems, A Baker, R Velleman. Routledge, London 2007; 197–217
   Google Scholar
• Teesson M, Burns L, National comorbidity project. Canberra: Department of Health and Aged Care, 2001.
   Google Scholar